Mikami S - Search Results

1

Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.

Hoshino Y, Hasegawa H, Ishii Y, Endo T, Ochiai H, Okabayashi K, Kaneko G, Mikami S, Mukai M, Oya M, Kitagawa Y. Hoshino Y, et al. Among authors: mikami s. Int J Clin Oncol. 2012 Aug;17(4):412-6. doi: 10.1007/s10147-011-0318-z. Epub 2011 Sep 17. Int J Clin Oncol. 2012. PMID: 21927829

2

Differential expression of activator protein-2 isoforms in renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Miyajima A, Horiguchi Y, Nakashima J, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: mikami s. Urology. 2004 Jul;64(1):162-7. doi: 10.1016/j.urology.2004.02.022. Urology. 2004. PMID: 15245963

3

EMR of a hyperplastic polyp arising in ectopic gastric mucosa in the cervical esophagus: case report.

Oguma J, Ozawa S, Omori T, Kitagawa Y, Saikawa Y, Mikami S, Kitajima M. Oguma J, et al. Among authors: mikami s. Gastrointest Endosc. 2005 Feb;61(2):335-8. doi: 10.1016/s0016-5107(04)02469-1. Gastrointest Endosc. 2005. PMID: 15729260 No abstract available.

4

C-jun activation in acquired cystic kidney disease and renal cell carcinoma.

Oya M, Mikami S, Mizuno R, Marumo K, Mukai M, Murai M. Oya M, et al. Among authors: mikami s. J Urol. 2005 Aug;174(2):726. doi: 10.1097/01.ju.0000164656.99251.77. J Urol. 2005. PMID: 16006965

5

Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis.

Mikami S, Oya M, Mizuno R, Murai M, Mukai M, Okada Y. Mikami S, et al. Cancer Sci. 2006 Sep;97(9):875-82. doi: 10.1111/j.1349-7006.2006.00268.x. Epub 2006 Jul 13. Cancer Sci. 2006. PMID: 16856880 Free PMC article.

6

Predominant expression of OLIG2 over ID2 in oligodendroglial tumors.

Mikami S, Hirose Y, Yoshida K, Kawase T, Ohnishi A, Nagashima K, Mukai M, Okada Y, Ikeda E. Mikami S, et al. Virchows Arch. 2007 May;450(5):575-84. doi: 10.1007/s00428-007-0394-7. Epub 2007 Mar 13. Virchows Arch. 2007. PMID: 17431671

7

Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.

Kosaka T, Mikami S, Miyajima A, Oya M. Kosaka T, et al. Among authors: mikami s. Clin Exp Nephrol. 2008 Apr;12(2):155-158. doi: 10.1007/s10157-007-0025-2. Epub 2008 Jan 22. Clin Exp Nephrol. 2008. PMID: 18209950

8

Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.

Kosaka T, Mikami S, Miyajima A, Kikuchi E, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Kosaka T, et al. Among authors: mikami s. Clin Exp Nephrol. 2008 Jun;12(3):195-9. doi: 10.1007/s10157-008-0041-x. Epub 2008 Mar 7. Clin Exp Nephrol. 2008. PMID: 18324351

9

Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.

Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M. Kanao K, et al. Among authors: mikami s. J Urol. 2008 Sep;180(3):1131-6. doi: 10.1016/j.juro.2008.04.136. Epub 2008 Jul 18. J Urol. 2008. PMID: 18639283

10

Combined gangliocytoma and prolactinoma of the pituitary gland.

Mikami S, Kameyama K, Takahashi S, Yoshida K, Kawase T, Sano T, Mukai M. Mikami S, et al. Endocr Pathol. 2008 Summer;19(2):117-21. doi: 10.1007/s12022-008-9027-1. Endocr Pathol. 2008. PMID: 18651251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

663 results

Search Page

Filters